Journal of Antimicrobial Chemotherapy (1994) 33, 253-263
© 1994 The British Society for Antimicrobial Chemotherapy
research-article |
Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole
Anti-Infective Research Division, Abbott Laboratories Illinois, USA
Received 1 February 1993; accepted 26 July 1993
The efficacy of clarithomycin and sulphamethoxazole for treatment of experimental Pneumocystis carinii infection was investigated. Rats were immunosuppressed with dexamethasone and inoculated intratracheally with 5 x 106 P. carinii cysts. After 2 weeks, the lung tissues were assayed for P. carinii cyst burden. The combination of clarithromycin and sulphamethoxazole caused a significantly greater reduction in cyst burden than either drug alone. Up to 50% of the rats treated with the combination of clarithromycin and sulphamethoxazole were negative for P. carinii cysts. Equivalent doses of the individual drugs given alone did not produce cures. The combination of clarithromycin and sulphamethoxazole was more than twice as effective as either drug alone. Clarithromycin combined with sulphamethoxazole in treatment of P. carinii infection could be especially useful since clarithromycin monotherapy provides safe and effective treatment against many other pathogens, including several that are associated with AIDS.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. Cirioni, A. Giacometti, F. Barchiesi, and G. Scalise Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline J. Antimicrob. Chemother., October 1, 2000; 46(4): 577 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cirioni, A. Giacometti, F. Barchiesi, M. Fortuna, and G. Scalise In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii J. Antimicrob. Chemother., November 1, 1999; 44(5): 653 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brun-Pascaud, P. Rajagopalan-Levasseur, F. Chau, G. Bertrand, L. Garry, F. Derouin, and P.-M. Girard Drug Evaluation of Concurrent Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium Complex Infections in a Rat Model Antimicrob. Agents Chemother., May 1, 1998; 42(5): 1068 - 1072. [Abstract] [Full Text] |
||||

